The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

A board-certified sleep medicine specialist reviews the history of wearable sleep trackers and explains how clinicians ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 ...

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 billion in 2024 and an impressive US$ 1.45 billion by 2029 ...

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ ...

Did you know that you can wear a ring to track your sleep habits?Melissa Lowry spoke with Brooke Mangum about sleep apnea and ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.

Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032, growing ...